Rhizen Pharma’s partnered asset Umbralisib gets US FDA accelerated nod for relapsed or refractory marginal zone lymphoma, follicular lymphoma Read more
Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30 countries Read more
SCHOTT increases global sales and earnings; India plant vital for fighting Coronavirus worldwide Read more